Second-line and beyond: treatment options for primary persistent and chronic immune thrombocytopenia
Sign Up to like & getrecommendations! Published in 2019 at "Platelets"
DOI: 10.1080/09537104.2019.1636018
Abstract: Abstract Less than 40% of patients with newly diagnosed adult immune thrombocytopenia will show spontaneous recovery within 12 months. Therefore, second-line treatments are frequently used to maintain a hemostatic platelet count or at best to… read more here.
Keywords: persistent chronic; line; primary persistent; immune thrombocytopenia ... See more keywords